Management expansion strengthens capabilities in developing new class of alpha radioligand therapies CAMBRIDGE, Mass. and OSLO, Norway and LONDON and BASEL, Switzerland, Oct. 5, 2023 /PRNewswire/ — ARTBIO, Inc. (ARTBIO), a clinical-stage radiopharmaceutical company developing a new class…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.